✦ LIBER ✦
Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients
✍ Scribed by Burke, M J; Trotz, B; Luo, X; Weisdorf, D J; Baker, K S; Wagner, J E; Verneris, M R
- Book ID
- 109840610
- Publisher
- Nature Publishing Group
- Year
- 2009
- Tongue
- English
- Weight
- 200 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.